Astrazeneca (AZN) Goodwill (2009 - 2026)

Astrazeneca has reported Goodwill for 18 years, with the latest figure at $21.2 billion in Q2 2026.

• On a quarterly basis, Goodwill changed 0.19% year-over-year to $21.2 billion in Q2 2026; TTM through Jun 2026 was $21.2 billion, a 0.19% change from a year earlier, with the FY2025 full-year figure at $21.2 billion, up 1.03% from the prior year.
• Goodwill was $21.2 billion for Q2 2026 at Astrazeneca, roughly flat from $21.2 billion in the prior quarter.
• The five-year high for Goodwill was $21.2 billion in Q4 2025, with the low at $19.7 billion in Q3 2022.
• Average Goodwill over 5 years is $20.5 billion, with a median of $20.5 billion recorded in 2023.
• The largest YoY upside for Goodwill was 69.68% in 2022 against a maximum downside of 1.86% in 2022.
• Over 5 years, Goodwill stood at $19.8 billion in 2022, then grew by 1.15% to $20.0 billion in 2023, then advanced by 4.87% to $21.0 billion in 2024, then advanced by 1.03% to $21.2 billion in 2025, then retreated by 0.29% to $21.2 billion in 2026.
• The last three Goodwill figures came in at $21.2 billion (Q2 2026), $21.2 billion (Q1 2026), and $21.2 billion (Q4 2025), per Business Quant data.